The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil
Document Type
Commentary
Publication Date
1-30-2020
Abstract
The International Contraceptive Access (ICA) Foundation was established in Finland in December 2003 as a public–private partnership between Bayer AG, a global pharmaceutical company, and the Population Council, an international nonprofit nongovernmental organization. The objective of the Foundation was to provide public service-delivery organizations with the levonorgestrel 52 mg intrauterine system (LNG IUS) on a not-for-profit basis to serve the reproductive needs of women in resource-poor settings in developing countries.
Recommended Citation
Miranda, Laura, John Townsend, Anibal Faundes, and Luis Bahamondes. 2020. "The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil," Contraception, https://doi.org/10.1016/j.contraception.2020.01.003.
DOI
10.1016/j.contraception.2020.01.003
Language
English